Spring Bank Pharmaceuticals Nasdaq Listed Banner

SEC Filing Details

Document Details

Form
Filing Date
Feb 6, 2018
Document Date
Mar 25, 2017
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Spring Bank Pharmaceuticals, Inc.
Issuer
Spring Bank Pha
Filer
UBS Oncology Impact Fund L.P.